Skip to search.

Breaking News Visit Yahoo! News for the latest.

×Close this window

 Dow Down1.35% Nasdaq Down1.12%

Amicus Therapeutics, Inc. (FOLD)

-NasdaqGM

2.46 Jun 19, 4:00PM EDT

Add to Portfolio
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingMar 30, 2013Dec 30, 2012Sep 29, 2012Jun 29, 2012
Total Revenue -   -   -   10,637  
Cost of Revenue -   -   -   -  
Gross Profit -   -   -   10,637  
Operating Expenses
Research Development11,989  11,047  11,499  13,723  
Selling General and Administrative4,823  4,455  4,995  5,819  
Non Recurring -   -   -   -  
Others439  421  422  442  
Total Operating Expenses -   -   -   -  
Operating Income or Loss (17,251) (15,923) (16,916) (9,347)
Income from Continuing Operations
Total Other Income/Expenses Net(197)2,675  645  19  
Earnings Before Interest And Taxes(17,448)(13,248)(16,271)(9,328)
Interest Expense10  12  19  15  
Income Before Tax(17,458)(13,260)(16,290)(9,343)
Income Tax Expense -  (3,245) -   -  
Minority Interest -   -   -   -  
Net Income From Continuing Ops(17,458)(10,015)(16,290)(9,343)
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (17,458) (10,015) (16,290) (9,343)
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares (17,458) (10,015) (16,290) (9,343)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.